PF-04171327

PF-04171327 · Pfizer

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PF-04171327, covering 2009-08-12 to 2023-11-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis [Phase 2]